Table 9.14 Neuroendocrine Interventions Summary (Mitchell & Owens, 1996)
| Condition | Treatment | Dosage & Delivery |
| Hypogonadism | Testosterone therapy (males)
Estrogen therapy (females) |
Oral therapy
Subcutaneous implant Intramuscular injection Transdermal patches and gels Short term treatment due to risks |
| ACTH Deficiency | Hydrocortisone
Prednisolone |
20mg in morning and 10mg in early evening given orally, intramuscularly, or IV
5-7.5mg/d given orally (1×/d) |
| TSH Deficiency | Synthetic TSH (Levothyroxine) | 1mg given orally before breakfast |
| GHD | Synthetic GH (Somatropin) or GHRH | 0.06mg/kg given subcutaneously or intramuscularly (3×/wk) |
| SIADH | ADH inhibitor (Conivaptan) | 20mg/d given by intravenous for short periods of time |
| DI | Desmopressin | 0.1-0.4mL/d intranasally |